Specialty-specific quality measures needed to improve outcomes in wound care

Written By Dianne Trim

Authors

William Tettelbach, MD, FACP, FIDSA, FUHM, MAPWCA, CHWS¹ ² ³*
Allyn Forsyth¹ ⁴

Corresponding Author: btettelbach@mimedx.com

Affiliations

¹ Medical Affairs, MIMEDX Group, Inc., Marietta, Georgia, USA.

² College of Podiatric Medicine, Western University of Health Sciences, Pomona, California, USA.

³ Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA.

⁴ Department of Biology, San Diego State University, San Diego, California, USA.

Dianne Trim
Previous

Cost-effectiveness of dehydrated human amnion/chorion membrane allografts in lower extremity diabetic ulcer treatment
Next

Real-world outcomes of cellular, acellular, and matrix-like products (CAMPs) in Stage 3 pressure injury ulcers: A matched Medicare claims analysis (2016–2024)